vs
FrontView REIT, Inc.（FVR）与RYTHM, Inc.（RYM）财务数据对比。点击上方公司名可切换其他公司
FrontView REIT, Inc.的季度营收约是RYTHM, Inc.的1.5倍（$16.5M vs $10.7M），FrontView REIT, Inc.净利率更高（-24.9% vs -127.6%，领先102.7%）
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
FVR vs RYM — 直观对比
营收规模更大
FVR
是对方的1.5倍
$10.7M
净利率更高
FVR
高出102.7%
-127.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.5M | $10.7M |
| 净利润 | $-4.1M | $-13.6M |
| 毛利率 | — | 75.5% |
| 营业利润率 | — | -121.5% |
| 净利率 | -24.9% | -127.6% |
| 营收同比 | — | 242.0% |
| 净利润同比 | — | 44.1% |
| 每股收益（稀释后） | $-0.19 | $-6.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRRYM
| Q4 25 | $16.5M | $10.7M | ||
| Q3 25 | $16.8M | $4.0M | ||
| Q2 25 | $17.6M | $2.0M | ||
| Q1 25 | $16.2M | $538.0K | ||
| Q4 24 | — | $-7.5M | ||
| Q3 24 | $14.5M | $1.9M | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $2.6M |
净利润FVRRYM
| Q4 25 | $-4.1M | $-13.6M | ||
| Q3 25 | $4.0M | $-10.7M | ||
| Q2 25 | $-2.9M | $-7.4M | ||
| Q1 25 | $-833.0K | $-1.6M | ||
| Q4 24 | — | $-24.4M | ||
| Q3 24 | $-2.4M | $-18.7M | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | — | $4.2M |
毛利率FVRRYM
| Q4 25 | — | 75.5% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 16.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 37.6% | ||
| Q1 24 | — | 6.4% |
营业利润率FVRRYM
| Q4 25 | — | -121.5% | ||
| Q3 25 | — | -219.8% | ||
| Q2 25 | — | -332.9% | ||
| Q1 25 | — | -687.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -63.1% | ||
| Q2 24 | — | -28.5% | ||
| Q1 24 | — | 13.6% |
净利率FVRRYM
| Q4 25 | -24.9% | -127.6% | ||
| Q3 25 | 23.9% | -263.8% | ||
| Q2 25 | -16.5% | -360.4% | ||
| Q1 25 | -5.1% | -302.2% | ||
| Q4 24 | — | 324.4% | ||
| Q3 24 | -16.7% | -964.4% | ||
| Q2 24 | — | -99.3% | ||
| Q1 24 | — | 163.0% |
每股收益（稀释后）FVRRYM
| Q4 25 | $-0.19 | $-6.78 | ||
| Q3 25 | $0.19 | $-5.33 | ||
| Q2 25 | $-0.16 | $-3.74 | ||
| Q1 25 | $-0.06 | $-0.83 | ||
| Q4 24 | — | $-24.26 | ||
| Q3 24 | — | $-17.28 | ||
| Q2 24 | — | $-3.16 | ||
| Q1 24 | — | $3.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.5M | $32.2M |
| 总债务越低越好 | $314.3M | $80.6M |
| 股东权益账面价值 | $391.2M | $13.0M |
| 总资产 | $854.4M | $106.7M |
| 负债/权益比越低杠杆越低 | 0.80× | 6.19× |
8季度趋势，按日历期对齐
现金及短期投资FVRRYM
| Q4 25 | $13.5M | $32.2M | ||
| Q3 25 | $19.6M | — | ||
| Q2 25 | $8.4M | $41.0M | ||
| Q1 25 | $3.3M | $24.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $267.0K | ||
| Q2 24 | — | $57.0K | ||
| Q1 24 | — | $99.0K |
总债务FVRRYM
| Q4 25 | $314.3M | $80.6M | ||
| Q3 25 | $307.1M | $90.6M | ||
| Q2 25 | $316.9M | $40.6M | ||
| Q1 25 | $310.2M | $10.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | — |
股东权益FVRRYM
| Q4 25 | $391.2M | $13.0M | ||
| Q3 25 | $385.2M | $11.7M | ||
| Q2 25 | $369.9M | $21.0M | ||
| Q1 25 | $324.7M | $26.8M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | $1.0K | $5.5M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $-5.5M |
总资产FVRRYM
| Q4 25 | $854.4M | $106.7M | ||
| Q3 25 | $846.8M | $115.2M | ||
| Q2 25 | $856.5M | $69.5M | ||
| Q1 25 | $860.8M | $45.6M | ||
| Q4 24 | — | $54.0M | ||
| Q3 24 | $1.0K | $39.0M | ||
| Q2 24 | — | $39.4M | ||
| Q1 24 | — | $40.6M |
负债/权益比FVRRYM
| Q4 25 | 0.80× | 6.19× | ||
| Q3 25 | 0.80× | 7.73× | ||
| Q2 25 | 0.86× | 1.94× | ||
| Q1 25 | 0.96× | 0.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.1M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FVRRYM
| Q4 25 | $42.1M | $-3.0M | ||
| Q3 25 | $8.3M | $-5.4M | ||
| Q2 25 | $9.3M | $-8.4M | ||
| Q1 25 | $8.1M | $-6.7M | ||
| Q4 24 | — | $-5.3M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-3.0M |
自由现金流FVRRYM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-3.0M |
自由现金流率FVRRYM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -61.2% | ||
| Q1 24 | — | -115.1% |
资本支出强度FVRRYM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率FVRRYM
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FVR
暂无分部数据
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
